Aligos Therapeutics, Inc. (ALGS), a clinical stage biopharmaceutical company focused on liver and viral diseases, announced Thursday ...

Merck & Co Inc (NYSE:MRK) released topline data from the HERTHENA-Lung02 phase 3 trial of patritumab deruxtecan in patients ...

Merck & Co Inc. (MRK) on Tuesday said HERTHENA-Lung02 phase 3 study evaluating Daiichi Sankyo and Merck's patritumab deruxtecan in ...

Australian researchers said that supervised diets with intermittent fasting were for children with serious health conditions, ...

Manchester United’s primary focus during the summer transfer window was strengthening at the back after the club conceded a ...

Only 6% of business leaders report that their organisation has completed at least one round of sustainability implementation.

With the 2024-25 season just weeks away from starting, here are three goals for Brooklyn Nets guard Cam Thomas as he heads ...

Incyte (INCY) and Syndax Pharmaceuticals (SNDX) announced that results from the pivotal Phase 2 AGAVE-201 trial of Niktimvo(axatilimab-csfr), an anti-CSF-1R antibody, in adult and pediatric patients ...

Whether you choose to own your primary residence or explore the benefits of renting it while investing in a secondary ...

Jose Molina shared his views on the defensive concerns about Mohun Bagan. Find out more insights about Mohun Bagan in details ...

Roche (OTCQX:RHHBY) subsidiary Genentech announced on Thursday that Xofluza, an FDA-approved flu antiviral, achieved its ...

In our latest Startup essentials article we hear from Lothbury Business Management on how a robust financial model can win ...